+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Structural Heart Devices Market Size, Share & Trends Analysis Report by Type (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Mitral Repair, Left Atrial Appendage Closure), by Region, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • August 2025
  • Region: Global
  • Grand View Research
  • ID: 5893187
The global structural heart devices market size was estimated at USD 16.13 billion in 2024 and is projected to reach USD 50.99 billion by 2033, growing at a CAGR of 13.5% from 2025 to 2033. Rising valvular heart diseases drive the growth of the market.

According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease stands at approximately 7,179 cases per 100,000 individuals, highlighting the substantial and persistent global burden of heart-related conditions. The rising prevalence of cardiovascular conditions highlights the need for timely interventions. Structural heart devices are key in managing valvular and congenital heart diseases. With a focus on early diagnosis and personalized care, technologies such as transcatheter valves and septal closure devices are improving outcomes and minimizing the need for invasive surgeries.

The rising prevalence of cardiovascular diseases (CVDs) in the U.S., including conditions such as arrhythmias and heart failure, is significantly driven by several key factors. A sedentary lifestyle has become increasingly common, with many individuals engaging in insufficient physical activity, which contributes to obesity and related health issues. According to the America Heart Association, in January 2024, the U.S. reported 931,578 deaths linked to cardiovascular disease, nearly 3,000 higher than the previous year, with the age-adjusted death rate climbing to 233.3 per 100,000 people, reflecting a 4.0% increase. These statistics underscore a growing need for advanced treatment options, such as transcatheter heart valves and left atrial appendage closure devices, to manage high-risk patients and reduce mortality linked to structural heart conditions.

Global Structural Heart Devices Market Report Segmentation

This report forecasts revenue growth and analyzes the latest trends in each sub-segments from 2021 to 2033 at the global, regional, and country levels. The analyst has segmented the global structural heart devices market report based on type and region:
  • Type Outlook (Revenue USD Million, 2021-2033)
  • TAVR (Transcatheter Aortic Valve Replacement)
  • SAVR (Surgical Aortic Valve Replacement)
  • Mitral Repair (Annuloplasty)
  • LAAC (Left Atrial Appendage Closure)

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.3. Competitive Insights
Chapter 3. Global Structural Heart Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising cardiovascular incidence
3.2.1.2. Increasing initiatives by the government and research bodies
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High cost of treatments
3.2.2.2. Regulatory challenges and approval delays
3.3. Global Structural Heart Devices: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Technology Landscape
3.5. Case Study Analysis
Chapter 4. Global Structural Heart Devices Market Segment Analysis, by Type, 2021-2033 (USD Million)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Structural Heart Devices Market, by Type, 2021 to 2033
4.5. TAVR (Transcatheter Aortic Valve Replacement)
4.5.1. TAVR (Transcatheter Aortic Valve Replacement) market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. SAVR (Surgical Aortic Valve Replacement)
4.6.1. SAVR (Surgical Aortic Valve Replacement) market estimates and forecasts, 2021 to 2033 (USD Million)
4.7. Mitral Repair (Annuloplasty)
4.7.1. Mitral Repair (Annuloplasty) market estimates and forecasts, 2021 to 2033 (USD Million)
4.8. LAAC (Left Atrial Appendage Closure)
4.8.1. LAAC (Left Atrial Appendage Closure) market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Structural Heart Devices Market Segment Analysis, by Region, 2021-2033 (USD Million)
5.1. Regional Market Share Analysis, 2024 & 2034
5.2. Regional Market Dashboard
5.3. Regional Market Snapshot
5.4. Structural Heart Devices Market Share by Region, 2024 & 2033:
5.5. North America
5.5.1. North America structural heart devices market, 2021-2033 (USD Million)
5.5.2. U.S.
5.5.2.1. Key Country Dynamics
5.5.2.2. Regulatory Scenario
5.5.2.3. Competitive Scenario
5.5.2.4. U.S. structural heart devices market, 2021-2033 (USD Million)
5.5.3. Canada
5.5.3.1. Key Country Dynamics
5.5.3.2. Regulatory Scenario
5.5.3.3. Competitive Scenario
5.5.3.4. Canada structural heart devices market, 2021-2033 (USD Million)
5.5.4. Mexico
5.5.4.1. Key Country Dynamics
5.5.4.2. Regulatory Scenario
5.5.4.3. Competitive Scenario
5.5.4.4. Mexico structural heart devices market, 2021-2033 (USD Million)
5.6. Europe
5.6.1. Europe structural heart devices market, 2021-2033 (USD Million)
5.6.2. UK
5.6.2.1. Key Country Dynamics
5.6.2.2. Regulatory Scenario
5.6.2.3. Competitive Scenario
5.6.2.4. UK structural heart devices market, 2021-2033 (USD Million)
5.6.3. Germany
5.6.3.1. Key Country Dynamics
5.6.3.2. Regulatory Scenario
5.6.3.3. Competitive Scenario
5.6.3.4. Germany structural heart devices market, 2021-2033 (USD Million)
5.6.4. France
5.6.4.1. Key Country Dynamics
5.6.4.2. Regulatory Scenario
5.6.4.3. Competitive Scenario
5.6.4.4. France structural heart devices market, 2021-2033 (USD Million)
5.6.5. Italy
5.6.5.1. Key Country Dynamics
5.6.5.2. Regulatory Scenario
5.6.5.3. Competitive Scenario
5.6.5.4. Italy structural heart devices market, 2021-2033 (USD Million)
5.6.6. Spain
5.6.6.1. Key Country Dynamics
5.6.6.2. Regulatory Scenario
5.6.6.3. Competitive Scenario
5.6.6.4. Spain structural heart devices market, 2021-2033 (USD Million)
5.6.7. Norway
5.6.7.1. Key Country Dynamics
5.6.7.2. Regulatory Scenario
5.6.7.3. Competitive Scenario
5.6.7.4. Norway structural heart devices market, 2021-2033 (USD Million)
5.6.8. Sweden
5.6.8.1. Key Country Dynamics
5.6.8.2. Regulatory Scenario
5.6.8.3. Competitive Scenario
5.6.8.4. Sweden structural heart devices market, 2021-2033 (USD Million)
5.6.9. Denmark
5.6.9.1. Key Country Dynamics
5.6.9.2. Regulatory Scenario
5.6.9.3. Competitive Scenario
5.6.9.4. Denmark structural heart devices market, 2021-2033 (USD Million)
5.7. Asia-Pacific
5.7.1. Japan
5.7.1.1. Key Country Dynamics
5.7.1.2. Regulatory Scenario
5.7.1.3. Competitive Scenario
5.7.1.4. Japan structural heart devices market, 2021-2033 (USD Million)
5.7.2. China
5.7.2.1. Key Country Dynamics
5.7.2.2. Regulatory Scenario
5.7.2.3. Competitive Scenario
5.7.2.4. China structural heart devices market, 2021-2033 (USD Million)
5.7.3. India
5.7.3.1. Key Country Dynamics
5.7.3.2. Regulatory Scenario
5.7.3.3. Competitive Scenario
5.7.3.4. India structural heart devices market, 2021-2033 (USD Million)
5.7.4. Australia
5.7.4.1. Key Country Dynamics
5.7.4.2. Regulatory Scenario
5.7.4.3. Competitive Scenario
5.7.4.4. Australia structural heart devices market, 2021-2033 (USD Million)
5.7.5. South Korea
5.7.5.1. Key Country Dynamics
5.7.5.2. Regulatory Scenario
5.7.5.3. Competitive Scenario
5.7.5.4. South Korea structural heart devices market, 2021-2033 (USD Million)
5.7.6. Thailand
5.7.6.1. Key Country Dynamics
5.7.6.2. Regulatory Scenario
5.7.6.3. Competitive Scenario
5.7.6.4. Thailand structural heart devices market, 2021-2033 (USD Million)
5.8. Latin America
5.8.1. Brazil
5.8.1.1. Key Country Dynamics
5.8.1.2. Regulatory Scenario
5.8.1.3. Competitive Scenario
5.8.1.4. Brazil structural heart devices market, 2021-2033 (USD Million)
5.8.2. Argentina
5.8.2.1. Key Country Dynamics
5.8.2.2. Regulatory Scenario
5.8.2.3. Competitive Scenario
5.8.2.4. Argentina structural heart devices market, 2021-2033 (USD Million)
5.9. MEA
5.9.1. South Africa
5.9.1.1. Key Country Dynamics
5.9.1.2. Regulatory Scenario
5.9.1.3. Competitive Scenario
5.9.1.4. South Africa structural heart devices market, 2021-2033 (USD Million)
5.9.2. Saudi Arabia
5.9.2.1. Key Country Dynamics
5.9.2.2. Regulatory Scenario
5.9.2.3. Competitive Scenario
5.9.2.4. Saudi Arabia structural heart devices market, 2021-2033 (USD Million)
5.9.3. UAE
5.9.3.1. Key Country Dynamics
5.9.3.2. Regulatory Scenario
5.9.3.3. Competitive Scenario
5.9.3.4. UAE structural heart devices market, 2021-2033 (USD Million)
5.9.4. Kuwait
5.9.4.1. Key Country Dynamics
5.9.4.2. Regulatory Scenario
5.9.4.3. Competitive Scenario
5.9.4.4. Kuwait structural heart devices market, 2021-2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
6.3.1. Boston Scientific Corporation
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Type benchmarking
6.3.1.4. Strategic initiatives
6.3.2. Medtronic plc
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Type benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Edwards Lifesciences Corporation
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Type benchmarking
6.3.3.4. Strategic initiatives
6.3.4. Abbott Laboratories
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Type benchmarking
6.3.4.4. Strategic initiatives
6.3.5. ST. JUDE MEDICAL
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Type benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Biomerics
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Type benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Comed BV
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Type benchmarking
6.3.7.4. Strategic initiatives
6.3.8. LivaNova PLC
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Type benchmarking
6.3.8.4. Strategic initiatives
6.3.9. JenaValve Technology, Inc.
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Type benchmarking
6.3.9.4. Strategic initiatives
6.3.10. CardioKinetix
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Type benchmarking
6.3.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 4 Global Structural Heart Devices Market, by Region, 2021-2033 (USD Million)
Table 5 North America Structural Heart Devices Market, by Country, 2021-2033 (USD Million)
Table 6 North America Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 7 U.S. Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 8 Canada Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 9 Mexico Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 10 Europe Structural Heart Devices Market, by Country, 2021-2033 (USD Million)
Table 11 Europe Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 12 UK Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 13 Germany Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 14 France Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 15 Italy Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 16 Spain Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 17 Denmark Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 18 Sweden Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 19 Norway Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 20 Asia-Pacific Structural Heart Devices Market, by Country, 2021-2033 (USD Million)
Table 21 Asia-Pacific Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 22 Japan Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 23 China Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 24 India Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 25 Australia Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 26 Thailand Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 27 South Korea Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 28 Latin America Structural Heart Devices Market, by Country, 2021-2033 (USD Million)
Table 29 Latin America Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 30 Brazil Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 31 Argentina Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 32 Middle East & Africa Structural Heart Devices Market, by Country, 2021-2033 (USD Million)
Table 33 Middle East & Africa Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 34 South Africa Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 35 Saudi Arabia Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 36 UAE Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
Table 37 Kuwait Structural Heart Devices Market, by Type, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Global structural heart devices market: outlook
Figure 9 Global structural heart devices competitive insights
Figure 10 Parent market outlook
Figure 11 Ancillary market outlook
Figure 12 Global structural heart devices market driver impact
Figure 13 Global structural heart devices market restraint impact
Figure 14 Porter’s Analysis
Figure 15 PESTLE Analysis
Figure 16 Global structural heart devices market: Type movement analysis
Figure 17 Global structural heart devices market: Type outlook and key takeaways
Figure 18 TAVR (Transcatheter Aortic Valve Replacement) market estimates and forecast, 2021-2033
Figure 19 SAVR (Surgical Aortic Valve Replacement) market estimates and forecast, 2021-2033
Figure 20 Mitral Repair (Annuloplasty) market estimates and forecast, 2021-2033
Figure 21 LAAC (Left Atrial Appendage Closure) market estimates and forecast, 2021-2033
Figure 22 Global structural heart devices market: Regional outlook and key takeaways
Figure 23 North America structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Key country dynamics
Figure 25 U.S. structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Key country dynamics
Figure 27 Canada structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Key country dynamics
Figure 29 Mexico structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Europe structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Key country dynamics
Figure 32 UK structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Key country dynamics
Figure 34 Germany structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Key country dynamics
Figure 36 Spain structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Key country dynamics
Figure 38 France structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Key country dynamics
Figure 40 Italy structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Key country dynamics
Figure 42 Norway structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Key country dynamics
Figure 44 Denmark structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Key country dynamics
Figure 46 Sweden structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Asia-Pacific structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Key country dynamics
Figure 49 Japan structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Key country dynamics
Figure 51 China structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Key country dynamics
Figure 53 India structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Key country dynamics
Figure 55 Australia structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 Key country dynamics
Figure 57 South Korea structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 Key country dynamics
Figure 59 Thailand structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 Latin America structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Key country dynamics
Figure 62 Brazil structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 Argentina structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 MEA structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 South Africa structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 Saudi Arabia structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 UAE structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Kuwait structural heart devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Key company categorization
Figure 75 Heat map analysis 2024

Companies Mentioned

The major companies profiled in this Structural Heart Devices market report include:
  • Boston Scientific Corporation
  • Medtronic
  • Edwards Lifesciences Corporation
  • Abbott Laboratories
  • ST. JUDE MEDICAL
  • Biomerics
  • Comed BV
  • LivaNova PLC
  • JenaValve Technology, Inc.
  • CardioKinetix

Table Information